|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,179.11 USD | +0.85% |
|
-0.80% | +9.72% |
| 07-17 | Novo Nordisk to launch lower-cost Ozempic copy in South Africa | RE |
| 07-17 | Eli Lilly Long-Term GLP-1 Franchise Faces Limited Generic Threat, UBS Says | MT |
| Market Cap | 1,051B 919B 848B 782B 1,473B 101,257B 1,506B 10,135B 3,986B 49,592B 3,949B 3,862B 170,718B | P/E 2026 * |
35x | P/E 2027 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1,070B 935B 863B 795B 1,498B 103,000B 1,532B 10,309B 4,055B 50,445B 4,017B 3,929B 173,657B | EV / Sales 2026 * |
12.5x | EV / Sales 2027 * | 10.6x |
| Free-Float |
99.84% | Yield 2026 * |
0.57% | Yield 2027 * | 0.64% |
Last Transcript: Eli Lilly and Company
| 1 day | +0.85% | ||
| 1 week | -0.80% | ||
| Current month | -1.69% | ||
| 1 month | +7.33% | ||
| 3 months | +27.19% | ||
| 6 months | +13.55% | ||
| Current year | +9.72% |
| 1 week | 1,134.4 |  | 1,196.29 |
| 1 month | 1,079.22 | | 1,249.45 |
| Current year | 850.51 | | 1,249.45 |
| 1 year | 623.78 | | 1,249.45 |
| 3 years | 446.56 | | 1,249.45 |
| 5 years | 220.2 | | 1,249.45 |
| 10 years | 64.18 | | 1,249.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 58 | 01/01/2017 |
Lucas Montarce
DFI | Director of Finance/CFO | 49 | 09/09/2024 |
| Chief Tech/Sci/R&D Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 66 | 01/01/2005 |
Ralph Alvarez
BRD | Director/Board Member | 70 | 01/04/2009 |
| Director/Board Member | 54 | 12/12/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/06/26 | Free | Director | 14 | 0.0000% | ||
| 15/06/26 | Free | Director | 11 | 0.0000% | ||
| 15/06/26 | Free | Director | 4 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | |
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | |
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | |
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | |
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | |
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | |
| -0.36% | +3.64% | +2.37% | -30.88% | 143B | |
| Average | -0.10% | +0.85% | +25.92% | +45.43% | 371.78B | |
| Weighted average by Cap. | +0.34% | +0.16% | +36.16% | +75.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 85.35B 74.58B 68.82B 63.44B 120B 8,219B 122B 823B 324B 4,025B 321B 313B 13,857B | 98.78B 86.32B 79.66B 73.42B 138B 9,513B 141B 952B 374B 4,659B 371B 363B 16,038B |
| Net income | 30.44B 26.6B 24.55B 22.62B 42.64B 2,931B 43.59B 293B 115B 1,436B 114B 112B 4,942B | 38.52B 33.66B 31.06B 28.63B 53.97B 3,710B 55.17B 371B 146B 1,817B 145B 141B 6,254B |
| Net Debt | 18.1B 15.82B 14.59B 13.45B 25.36B 1,743B 25.92B 174B 68.61B 854B 67.97B 66.48B 2,938B | -3.5B -3.06B -2.82B -2.6B -4.91B -337B -5.02B -33.75B -13.28B -165B -13.15B -12.86B -569B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | $1,179.11 | +0.85% | 2,757,541 |
| 16/07/26 | $1,169.17 | +1.08% | 2,791,060 |
| 15/07/26 | $1,156.63 | +0.35% | 2,552,230 |
| 14/07/26 | $1,152.54 | -2.48% | 2,642,940 |
| 13/07/26 | $1,181.87 | -0.56% | 2,072,666 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LLY Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition